home.social

#jn1variant — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #jn1variant, aggregated by home.social.

fetched live
  1. The fast-spreading COVID-19 variant "JN.1" is now the most prevalent in the U.S., accounting for 44%+ of cases.

    JN.1's surge suggests it's either more transmissible or better at evading our immune systems than other strains per CDC.

    "New COVID strain JN.1 quickly becomes most dominant in U.S." - Axios
    axios.com/2023/12/26/new-covid

    #covid #JN1Variant

  2. The fast-spreading COVID-19 variant "JN.1" is now the most prevalent in the U.S., accounting for 44%+ of cases.

    JN.1's surge suggests it's either more transmissible or better at evading our immune systems than other strains per CDC.

    "New COVID strain JN.1 quickly becomes most dominant in U.S." - Axios
    axios.com/2023/12/26/new-covid

    #covid #JN1Variant

  3. The fast-spreading COVID-19 variant "JN.1" is now the most prevalent in the U.S., accounting for 44%+ of cases.

    JN.1's surge suggests it's either more transmissible or better at evading our immune systems than other strains per CDC.

    "New COVID strain JN.1 quickly becomes most dominant in U.S." - Axios
    axios.com/2023/12/26/new-covid

    #covid #JN1Variant

  4. The fast-spreading COVID-19 variant "JN.1" is now the most prevalent in the U.S., accounting for 44%+ of cases.

    JN.1's surge suggests it's either more transmissible or better at evading our immune systems than other strains per CDC.

    "New COVID strain JN.1 quickly becomes most dominant in U.S." - Axios
    axios.com/2023/12/26/new-covid

    #covid #JN1Variant

  5. The fast-spreading COVID-19 variant "JN.1" is now the most prevalent in the U.S., accounting for 44%+ of cases.

    JN.1's surge suggests it's either more transmissible or better at evading our immune systems than other strains per CDC.

    "New COVID strain JN.1 quickly becomes most dominant in U.S." - Axios
    axios.com/2023/12/26/new-covid

    #covid #JN1Variant

  6. JN.1 sub-variant: The Additional Public Health Risk Is Low at the Global Level  
    JN.1 sub-variant whose earliest documented sample was reported on 25 August2023 and which was later reported by the researchers to have higher...........
    #COVID #COVID19 #JN1variant #Variants #WHO
    SCIEU Team

    scientificeuropean.co.uk/covid

  7. JN.1 sub-variant: The Additional Public Health Risk Is Low at the Global Level  
    JN.1 sub-variant whose earliest documented sample was reported on 25 August2023 and which was later reported by the researchers to have higher...........
    #COVID #COVID19 #JN1variant #Variants #WHO
    SCIEU Team

    scientificeuropean.co.uk/covid

  8. JN.1 sub-variant: The Additional Public Health Risk Is Low at the Global Level  
    JN.1 sub-variant whose earliest documented sample was reported on 25 August2023 and which was later reported by the researchers to have higher...........
    #COVID #COVID19 #JN1variant #Variants #WHO
    SCIEU Team

    scientificeuropean.co.uk/covid

  9. JN.1 sub-variant: The Additional Public Health Risk Is Low at the Global Level  
    JN.1 sub-variant whose earliest documented sample was reported on 25 August2023 and which was later reported by the researchers to have higher...........
    #COVID #COVID19 #JN1variant #Variants #WHO
    SCIEU Team

    scientificeuropean.co.uk/covid

  10. JN.1 sub-variant: The Additional Public Health Risk Is Low at the Global Level  
    JN.1 sub-variant whose earliest documented sample was reported on 25 August2023 and which was later reported by the researchers to have higher...........
    #COVID #COVID19 #JN1variant #Variants #WHO
    SCIEU Team

    scientificeuropean.co.uk/covid

  11. COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 
    Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to...........
    #Coronavirus #COVID #COVID19 #JN1variant #Variants
    Umesh Prasad

    scientificeuropean.co.uk/covid

  12. COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 
    Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to...........
    #Coronavirus #COVID #COVID19 #JN1variant #Variants
    Umesh Prasad

    scientificeuropean.co.uk/covid

  13. COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 
    Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to...........
    #Coronavirus #COVID #COVID19 #JN1variant #Variants
    Umesh Prasad

    scientificeuropean.co.uk/covid

  14. COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 
    Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to...........
    #Coronavirus #COVID #COVID19 #JN1variant #Variants
    Umesh Prasad

    scientificeuropean.co.uk/covid

  15. COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 
    Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to...........
    #Coronavirus #COVID #COVID19 #JN1variant #Variants
    Umesh Prasad

    scientificeuropean.co.uk/covid

  16. COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 
    Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to...........
    #Coronavirus #COVID #COVID19 #JN1variant #Variants
    Umesh Prasad

    scientificeuropean.co.uk/covid

  17. COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 
    Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to...........
    #Coronavirus #COVID #COVID19 #JN1variant #Variants
    Umesh Prasad

    scientificeuropean.co.uk/covid

  18. COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 
    Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to...........
    #Coronavirus #COVID #COVID19 #JN1variant #Variants
    Umesh Prasad

    scientificeuropean.co.uk/covid

  19. COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 
    Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to...........
    #Coronavirus #COVID #COVID19 #JN1variant #Variants
    Umesh Prasad

    scientificeuropean.co.uk/covid

  20. COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 
    Spike mutation (S: L455S) is hallmark mutation of JN.1 sub-variant which significantly enhances its immune evasion capability enabling it to...........
    #Coronavirus #COVID #COVID19 #JN1variant #Variants
    Umesh Prasad

    scientificeuropean.co.uk/covid